2018
DOI: 10.1016/j.autrev.2017.10.015
|View full text |Cite
|
Sign up to set email alerts
|

Altered B lymphocyte homeostasis and functions in systemic sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
59
0
3

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(64 citation statements)
references
References 67 publications
2
59
0
3
Order By: Relevance
“…Although randomized double-blind clinical trials examining the utility of B cell depletion therapy in SSc have not been performed, some studies have reported clinical improvement with rituximab, especially in the context of early diffuse SSc (22,23). Additionally, activated B cells have been observed in the circulation of SSc patients (24,36). Although there may be a contribution of infiltrating B cells to pathology in SSc, we focused on the T cells in the infiltrate across this group of patients given their relative preponderance in the tissue.…”
Section: Resultsmentioning
confidence: 99%
“…Although randomized double-blind clinical trials examining the utility of B cell depletion therapy in SSc have not been performed, some studies have reported clinical improvement with rituximab, especially in the context of early diffuse SSc (22,23). Additionally, activated B cells have been observed in the circulation of SSc patients (24,36). Although there may be a contribution of infiltrating B cells to pathology in SSc, we focused on the T cells in the infiltrate across this group of patients given their relative preponderance in the tissue.…”
Section: Resultsmentioning
confidence: 99%
“…It is possible that these B cells are linked with the production of higher affinity antibodies relevant in inflammation. Indeed, subsets of memory B cell shave been reported to dysregulated in other autoimmune diseases such as systemic lupus erythematosus and multiple sclerosis[18]. Based on the reported pathogenic role of B cell in other autoimmune diseases[11], we anticipated that also plays an important role in etiology of IgAV.…”
Section: Discussionmentioning
confidence: 98%
“…Both subsets expressed a high level expression of ectopic membrane hMSH2 proteins. CD25, the interleukin‐2 receptor alpha chain, is one of the activation biomarkers for human B‐cells . It has been reported serving as a negative growth regulator, a novel marker and potential drug target in chronic myeloid leukaemia .…”
Section: Discussionmentioning
confidence: 99%